EMD-26064

Single-particle
8.64 Å
EMD-26064
3D View Gallery
Deposition: 26/01/2022
Map released: 09/03/2022
Last modified: 17/01/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-26064

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

SARS-CoV-2 S + Fabs 5317-4 and 5217-10

EMD-26064

Single-particle
8.64 Å
EMD-26064
3D View Gallery
Deposition: 26/01/2022
Map released: 09/03/2022
Last modified: 17/01/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2
Sample: Complex of SARS-CoV-2 S-ECD with Fabs 5317-4 and 5317-10

Deposition Authors: Johnson NV , McLellan JS
Efficient discovery of SARS-CoV-2-neutralizing antibodies via B cell receptor sequencing and ligand blocking.
Shiakolas AR , Kramer KJ , Johnson NV , Wall SC, Suryadevara N , Wrapp D , Periasamy S , Pilewski KA , Raju N, Nargi R, Sutton RE, Walker LM, Setliff I , Crowe Jr JE , Bukreyev A , Carnahan RH , McLellan JS , Georgiev IS
(2022) Nat Biotechnol , 40 , 1270 - 1275
PUBMED: 35241839
DOI: doi:10.1038/s41587-022-01232-2
ISSN: 1087-0156
ASTM: NABIF9